Click on the green arrow on the right of the picture to see the slides. The arrows on the top right then allow you to move back and forth between them.
To see all the slides on the same page, click here.
| Key stats | |
|---|---|
| Dividend yield | 3.4% |
| Market capitalisation | £261m |
| No. of shares out | 102m |
| No. of shares floating | 58m |
| No. of employees | 4,700 |
| Trading volume (10 day avg.) | 0.1m |
| Turnover | £400m |
| Profit before tax | £28m |
| Earnings per share | 14.09p |
| Cashflow per share | 23.60p |
| Cash per share | 2.24p |
Clipper Logistics (CLG)
Who’s trading? Citywire AAA-rated Anthony Cross & Julian Fosh
The trade: Liontrust’s UK equity stars again upped their stake in warehouse and delivery firm Clipper Logistics from 13.4% of the shares to 14%.
How have the shares performed? Clipper, which works with high street majors such as John Lewis and Marks and Spencer, has halved from 475p in early 2018 to Friday’s 239p as a chill wind has blown through UK retail.
What does the company say? Despite investors treating it as a direct proxy on battered bricks and mortar retail, Clipper pointed out its pre-tax profit climbed almost 17% in six months to November on a 17% increase in the revenue generated by online deliveries. ‘We have a strong new business pipeline,’ the company added.
What’s the outlook? The company also reported a potential boost to its warehousing division last month saying customers, especially tobacco firms, were stockpiling inventory to guard against any Brexit disruption. Analysts rate it a ‘buy’ on a two-to-one margin on a median target price of 391p.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 0% |
| Market capitalisation | £42m |
| No. of shares out | 160m |
| No. of shares floating | 150m |
| No. of employees | 60 |
| Trading volume (10 day avg.) | 0.1m |
| Turnover | £25m |
| Profit before tax | £-11m |
| Earnings per share | -10.90p |
| Cashflow per share | -10.52p |
| Cash per share | 27.33p |
Summit Therapeutics (SUMM)
Who’s trading? AAA-rated David Pinniger
The trade: Polar Capital’s biotech star upped his stake in UK sector champion Summit Therapeutics from 0.7% of shares to 6.4% worth around £1.1 million.
How have the shares performed? Summit plummeted from 190p in June last year after reporting that a treatment for a rare fatal muscle disorder had flopped in trials, and remains almost 90% lower, trading on Friday at 26p.
What does the company say? Backers have severely downgraded the closely-held stock, but the firm convinced billionaire veteran biotech executive Robert Duggan to invest $25 million (£19.8 million) last month at around 25p a share. Losses sharply widened at the end of 2018 but the business pointed out it remained well-capitalised.
What’s the outlook? While loss-making businesses are par for the course in the highly speculative biotech sector, the near nine-fold plunge into the red in the three months to November, from a loss of £900,000 out to £8.1 million, is still considered a steep and sudden change of fortune.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 8.4% |
| Market capitalisation | £423m |
| No. of shares out | 199m |
| No. of shares floating | 197m |
| No. of employees | 11,186 |
| Trading volume (10 day avg.) | 0.6m |
| Turnover | £1,135m |
| Profit before tax | £114m |
| Earnings per share | 27.54p |
| Cashflow per share | 45.12p |
| Cash per share | 13.56p |
Zotefoams (ZTF)
Who’s trading? Citywire A-rated Roland Arnold
The trade: The BlackRock UK small cap manager was among a series of holders to recently top slice their stake in Zotefoams, from 11.5% of the shares to 10.7%.
How have the shares performed? Shares rocketed in late December after fund giant Oppenheimer revealed it had taken a stake of more than 5%, hitting an all-time record of 706p, and were on Friday trading at 674p.
What does the company say? The high-tech materials business reported ‘record’ third quarter sales as it upgraded its profit forecast for the first nine months of the year, on a 16% increase in revenue for the period. Boss David Stirling said the firm had made ‘substantial progress’ and he was ‘confident about the future prospects’.
What’s the outlook? City brokers rate the stock a ‘buy’ at a ratio of three to two but the surge of interest has carried shares to well above a median price target of 606p and a price-to-earnings multiple of 30 times next year’s forecast, almost three times richer than the sector average.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 6.5% |
| Market capitalisation | £58m |
| No. of shares out | 16m |
| No. of shares floating | 15m |
| No. of employees | 195 |
| Trading volume (10 day avg.) | 0m |
| Turnover | £22m |
| Profit before tax | £5m |
| Earnings per share | 22.73p |
| Cashflow per share | 29.88p |
| Cash per share | 91.16p |
Zytronic (ZYT)
Who’s trading? Citywire AAA-rated James Baker
The trade: Chelverton’s UK growth fund manager increased his stake in touch screen manufacturer Zytronic from 5% to 7.5%.
How have the shares performed? The firm has had its share of troubles over the last 12 months, with the shares falling from around 500p to 370.5p.
What does the company say? A slowdown in sales at the touch screen technology business impacted profitability, with pre-tax profit in the year to September falling 22% to £4.2 million on revenue of £22.3 million, down 3%. The company’s shares fell on the back of the results, which it said were impacted by the performance of the financial market.
What’s the outlook? The management of the company said that over the next year it would look to improve margins by securing new projects and creating efficiencies in production. Zytronic is set to demo a new hybrid touch technology in February. And despite lower profits the business was able to increase dividends for shareholders by 20%.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 4.4% |
| Market capitalisation | £110m |
| No. of shares out | 21m |
| No. of shares floating | 14m |
| No. of employees | 186 |
| Trading volume (10 day avg.) | 0m |
| Turnover | £106m |
| Profit before tax | £14m |
| Earnings per share | 44.38p |
| Cashflow per share | 53.07p |
| Cash per share | 163.20p |
Character Group (CCT)
Who’s trading? Man GLG’s Henry Dixon
The trade: Dixon has reduced his holding in the international toy and game distribution company Character Group, held across his UK Income and UK Undervalued Assets funds, from 6.1% to under 5%.
How have the shares performed? The AIM-listed firm’s shares have risen from around 450p 12 months ago to 510p. The company posted an upbeat trading update in September, saying profits were in line with market expectations and it was confident its tie-up with Danish firm Proxy will be a driver of growth.
What does the company say? Character Group reported record sales in the second half of the year, with its established ranges, including Peppa Pig and Teletubbies in demand, while new products such as Pokémon and Treasure X performed strongly.
What’s the outlook? The company’s management was upbeat heading into the key Christmas trading period, highlighting its push into ‘craze’ or impulse purchase items, such as Cakepop Cuties and Cra.Z.Slimy. It has also announced a £5 million share buyback programme.
Leave a comment!
Click on the green arrow on the right of the picture to see the slides. The arrows on the top right then allow you to move back and forth between them.
To see all the slides on the same page, click here.
Leave a comment!
Click on the green arrow on the right of the picture to see the slides. The arrows on the top right then allow you to move back and forth between them.
To see all the slides on the same page, click here.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 3.4% |
| Market capitalisation | £261m |
| No. of shares out | 102m |
| No. of shares floating | 58m |
| No. of employees | 4,700 |
| Trading volume (10 day avg.) | 0.1m |
| Turnover | £400m |
| Profit before tax | £28m |
| Earnings per share | 14.09p |
| Cashflow per share | 23.60p |
| Cash per share | 2.24p |
Clipper Logistics (CLG)
Who’s trading? Citywire AAA-rated Anthony Cross & Julian Fosh
The trade: Liontrust’s UK equity stars again upped their stake in warehouse and delivery firm Clipper Logistics from 13.4% of the shares to 14%.
How have the shares performed? Clipper, which works with high street majors such as John Lewis and Marks and Spencer, has halved from 475p in early 2018 to Friday’s 239p as a chill wind has blown through UK retail.
What does the company say? Despite investors treating it as a direct proxy on battered bricks and mortar retail, Clipper pointed out its pre-tax profit climbed almost 17% in six months to November on a 17% increase in the revenue generated by online deliveries. ‘We have a strong new business pipeline,’ the company added.
What’s the outlook? The company also reported a potential boost to its warehousing division last month saying customers, especially tobacco firms, were stockpiling inventory to guard against any Brexit disruption. Analysts rate it a ‘buy’ on a two-to-one margin on a median target price of 391p.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 0% |
| Market capitalisation | £42m |
| No. of shares out | 160m |
| No. of shares floating | 150m |
| No. of employees | 60 |
| Trading volume (10 day avg.) | 0.1m |
| Turnover | £25m |
| Profit before tax | £-11m |
| Earnings per share | -10.90p |
| Cashflow per share | -10.52p |
| Cash per share | 27.33p |
Summit Therapeutics (SUMM)
Who’s trading? AAA-rated David Pinniger
The trade: Polar Capital’s biotech star upped his stake in UK sector champion Summit Therapeutics from 0.7% of shares to 6.4% worth around £1.1 million.
How have the shares performed? Summit plummeted from 190p in June last year after reporting that a treatment for a rare fatal muscle disorder had flopped in trials, and remains almost 90% lower, trading on Friday at 26p.
What does the company say? Backers have severely downgraded the closely-held stock, but the firm convinced billionaire veteran biotech executive Robert Duggan to invest $25 million (£19.8 million) last month at around 25p a share. Losses sharply widened at the end of 2018 but the business pointed out it remained well-capitalised.
What’s the outlook? While loss-making businesses are par for the course in the highly speculative biotech sector, the near nine-fold plunge into the red in the three months to November, from a loss of £900,000 out to £8.1 million, is still considered a steep and sudden change of fortune.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 8.4% |
| Market capitalisation | £423m |
| No. of shares out | 199m |
| No. of shares floating | 197m |
| No. of employees | 11,186 |
| Trading volume (10 day avg.) | 0.6m |
| Turnover | £1,135m |
| Profit before tax | £114m |
| Earnings per share | 27.54p |
| Cashflow per share | 45.12p |
| Cash per share | 13.56p |
Zotefoams (ZTF)
Who’s trading? Citywire A-rated Roland Arnold
The trade: The BlackRock UK small cap manager was among a series of holders to recently top slice their stake in Zotefoams, from 11.5% of the shares to 10.7%.
How have the shares performed? Shares rocketed in late December after fund giant Oppenheimer revealed it had taken a stake of more than 5%, hitting an all-time record of 706p, and were on Friday trading at 674p.
What does the company say? The high-tech materials business reported ‘record’ third quarter sales as it upgraded its profit forecast for the first nine months of the year, on a 16% increase in revenue for the period. Boss David Stirling said the firm had made ‘substantial progress’ and he was ‘confident about the future prospects’.
What’s the outlook? City brokers rate the stock a ‘buy’ at a ratio of three to two but the surge of interest has carried shares to well above a median price target of 606p and a price-to-earnings multiple of 30 times next year’s forecast, almost three times richer than the sector average.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 6.5% |
| Market capitalisation | £58m |
| No. of shares out | 16m |
| No. of shares floating | 15m |
| No. of employees | 195 |
| Trading volume (10 day avg.) | 0m |
| Turnover | £22m |
| Profit before tax | £5m |
| Earnings per share | 22.73p |
| Cashflow per share | 29.88p |
| Cash per share | 91.16p |
Zytronic (ZYT)
Who’s trading? Citywire AAA-rated James Baker
The trade: Chelverton’s UK growth fund manager increased his stake in touch screen manufacturer Zytronic from 5% to 7.5%.
How have the shares performed? The firm has had its share of troubles over the last 12 months, with the shares falling from around 500p to 370.5p.
What does the company say? A slowdown in sales at the touch screen technology business impacted profitability, with pre-tax profit in the year to September falling 22% to £4.2 million on revenue of £22.3 million, down 3%. The company’s shares fell on the back of the results, which it said were impacted by the performance of the financial market.
What’s the outlook? The management of the company said that over the next year it would look to improve margins by securing new projects and creating efficiencies in production. Zytronic is set to demo a new hybrid touch technology in February. And despite lower profits the business was able to increase dividends for shareholders by 20%.
Leave a comment!
| Key stats | |
|---|---|
| Dividend yield | 4.4% |
| Market capitalisation | £110m |
| No. of shares out | 21m |
| No. of shares floating | 14m |
| No. of employees | 186 |
| Trading volume (10 day avg.) | 0m |
| Turnover | £106m |
| Profit before tax | £14m |
| Earnings per share | 44.38p |
| Cashflow per share | 53.07p |
| Cash per share | 163.20p |
Character Group (CCT)
Who’s trading? Man GLG’s Henry Dixon
The trade: Dixon has reduced his holding in the international toy and game distribution company Character Group, held across his UK Income and UK Undervalued Assets funds, from 6.1% to under 5%.
How have the shares performed? The AIM-listed firm’s shares have risen from around 450p 12 months ago to 510p. The company posted an upbeat trading update in September, saying profits were in line with market expectations and it was confident its tie-up with Danish firm Proxy will be a driver of growth.
What does the company say? Character Group reported record sales in the second half of the year, with its established ranges, including Peppa Pig and Teletubbies in demand, while new products such as Pokémon and Treasure X performed strongly.
What’s the outlook? The company’s management was upbeat heading into the key Christmas trading period, highlighting its push into ‘craze’ or impulse purchase items, such as Cakepop Cuties and Cra.Z.Slimy. It has also announced a £5 million share buyback programme.
Leave a comment!